Coral Laboratories Ltd

BSE:CORALAB

HealthcarePharmaceuticals & Biotechnology

₹548.6

-3.42%1 Oct close

Mkt cap

₹197 Cr

Watch Alert Compare

Quarterly Annual

Year ends (Mar) · % of equity

Holder (%)	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	71.51%	71.51%	71.51%	71.51%	71.51%
FII	0%	0.14%	0.14%	0%	0%
DII	0%	0%	0%	0%	0%
	0%	0%	0%	0%	0%
	28.49%	28.35%	28.35%	28.49%	28.49%
No. of shareholders	—	—	—	—	4,084

Promoter holding up 0 percentage points since Mar 2022. One column per financial year, taken from the register filed at that year end.

4 deals · 13 Dec 2021 – 24 May 2024

Date	Client	Type	Venue	Side	Quantity	Price	Value
24 May 2024	NEELAM MITTAL	Bulk	BSE	Buy	21,709	₹537.82	₹1.17 Cr
24 May 2024	NEELAM MITTAL	Bulk	BSE	Sell	1,100	₹539.62	₹0.06 Cr
8 Sept 2022	VAIBHAV RAJENDRA DOSHI	Bulk	BSE	Sell	19,050	₹276.48	₹0.53 Cr
13 Dec 2021	GUTTIKONDA VARA LAKSHMI	Bulk	BSE	Sell	20,000	₹286.89	₹0.57 Cr

1–4 of 4

1 / 1

Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.

Mrs. SUSHMA KADKADENon-Executive - Non Independent Director-Chairperson
Mr. GIRISH DHAMEJAExecutive Director
Mr. SAURABH SHAHNon-Executive - Independent Director
Mr. MALAY DOSHINon-Executive - Independent Director
Mr. RAJENDRASINH RANANon-Executive - Non Independent Director
Ms. POOJA HINDIANon-Executive - Independent Director
Mrs. SUSHMA KADKADEChief Financial Officer
Mr. Diwakar Unnikrishna MenonCompany Secretary & Compliance Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Coral Laboratories Ltd

Annual record

Bulk & block deals

Board and management